ArticleJournal of personalized medicine2021

Sweat Chloride Testing and Nasal Potential Difference (NPD) Are Primary Outcome Parameters in Treatment with Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators.

Isabelle Sermet-Gaudelus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.